H. Roger Brown

A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.

Kathleen K. Brown, Brad R. Henke, Steven G. Blanchard et al. · Diabetes · 1999 · 168 citations

Medicine, Endocrinology, Pharmacology +17

Activation of the Nuclear Receptor Peroxisome Proliferator-activated Receptor γ Promotes Brown Adipocyte Differentiation

Tzu-Ann C. Tai, Caroline Jennermann, Kathleen K. Brown et al. · Journal of Biological Chemistry · 1996 · 154 citations · Full text

Life Sciences, Molecular Biology, Physiology +17

Dissection of the Molecular Mechanism of Action of GW5638, a Novel Estrogen Receptor Ligand, Provides Insights into the Role of Estrogen Receptor in Bone*

Timothy M. Willson, John D. Norris, B L Wagner et al. · Endocrinology · 1997 · 122 citations

Medicine, Endocrinology, Pharmacology +16

The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancreatic beta-cell dysfunction

James M. Lenhard, Mary E. Lancaster, Mark Paulik et al. · Diabetologia · 1999 · 84 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Potential urinary and plasma biomarkers of peroxisome proliferation in the rat: identification of<i>N</i>-methylnicotinamide and<i>N</i>-methyl-4-pyridone-3-carboxamide by¹H nuclear magnetic resonance and high performance liquid chromatography

Stéphanie Ringeissen, Susan C. Connor, H. Roger Brown et al. · Biomarkers · 2003 · 72 citations

Medicine, Pharmacology, Biochemical Pharmacology +10